194 related articles for article (PubMed ID: 9516855)
1. HuD, a neuronal-specific RNA-binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells.
Ross RA; Lazarova DL; Manley GT; Smitt PS; Spengler BA; Posner JB; Biedler JL
Eur J Cancer; 1997 Oct; 33(12):2071-4. PubMed ID: 9516855
[TBL] [Abstract][Full Text] [Related]
2. HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts.
Lazarova DL; Spengler BA; Biedler JL; Ross RA
Oncogene; 1999 Apr; 18(17):2703-10. PubMed ID: 10348344
[TBL] [Abstract][Full Text] [Related]
3. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
Ball NS; King PH
Clin Cancer Res; 1997 Oct; 3(10):1859-65. PubMed ID: 9815574
[TBL] [Abstract][Full Text] [Related]
4. Activity of a 40 kDa RNA-binding protein correlates with MYCN and c-fos mRNA stability in human neuroblastoma.
Chagnovich D; Cohn SL
Eur J Cancer; 1997 Oct; 33(12):2064-7. PubMed ID: 9516853
[TBL] [Abstract][Full Text] [Related]
5. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
Manley GT; Smitt PS; Dalmau J; Posner JB
Ann Neurol; 1995 Jul; 38(1):102-10. PubMed ID: 7541976
[TBL] [Abstract][Full Text] [Related]
6. RNA-binding analyses of HuC and HuD with the VEGF and c-myc 3'-untranslated regions using a novel ELISA-based assay.
King PH
Nucleic Acids Res; 2000 Apr; 28(7):E20. PubMed ID: 10710437
[TBL] [Abstract][Full Text] [Related]
7. HuD, a neuronal-specific RNA-binding protein, increases the in vivo stability of MYCN RNA.
Manohar CF; Short ML; Nguyen A; Nguyen NN; Chagnovich D; Yang Q; Cohn SL
J Biol Chem; 2002 Jan; 277(3):1967-73. PubMed ID: 11711535
[TBL] [Abstract][Full Text] [Related]
8. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
Spengler BA; Lazarova DL; Ross RA; Biedler JL
Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
[TBL] [Abstract][Full Text] [Related]
9. Differential activity of ELAV-like RNA-binding proteins in human neuroblastoma.
Chagnovich D; Fayos BE; Cohn SL
J Biol Chem; 1996 Dec; 271(52):33587-91. PubMed ID: 8969226
[TBL] [Abstract][Full Text] [Related]
10. Binding of a 40-kDa protein to the N-myc 3'-untranslated region correlates with enhanced N-myc expression in human neuroblastoma.
Chagnovich D; Cohn SL
J Biol Chem; 1996 Dec; 271(52):33580-6. PubMed ID: 8969225
[TBL] [Abstract][Full Text] [Related]
11. Expression of HuD (a paraneoplastic encephalomyelitis antigen) mRNA in lung cancer.
Cho JH; Noguchi M
J Korean Med Sci; 1997 Aug; 12(4):305-10. PubMed ID: 9288629
[TBL] [Abstract][Full Text] [Related]
12. The RNA binding protein HuD: rat cDNA and analysis of the alternative spliced mRNA in neuronal differentiating cell lines P19 and PC12.
Steller U; Kohls S; Müller B; Söller R; Müller R; Schlender J; Blohm DH
Brain Res Mol Brain Res; 1996 Jan; 35(1-2):285-96. PubMed ID: 8717365
[TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor mRNA binding-protein IMP-1 and the Ras-regulatory protein G3BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells.
Atlas R; Behar L; Elliott E; Ginzburg I
J Neurochem; 2004 May; 89(3):613-26. PubMed ID: 15086518
[TBL] [Abstract][Full Text] [Related]
14. Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis.
Graus YF; Verschuuren JJ; Degenhardt A; van Breda Vriesman PJ; De Baets MH; Posner JB; Burton DR; Dalmau J
J Neuroimmunol; 1998 Mar; 82(2):200-9. PubMed ID: 9585817
[TBL] [Abstract][Full Text] [Related]
15. Neuronal HuD gene encoding a mRNA stability regulator is transcriptionally repressed by thyroid hormone.
Cuadrado A; Navarro-Yubero C; Furneaux H; Muñoz A
J Neurochem; 2003 Aug; 86(3):763-73. PubMed ID: 12859688
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA.
Liu J; Dalmau J; Szabo A; Rosenfeld M; Huber J; Furneaux H
Neurology; 1995 Mar; 45(3 Pt 1):544-50. PubMed ID: 7898713
[TBL] [Abstract][Full Text] [Related]
17. Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility.
De Giorgio R; Bovara M; Barbara G; Canossa M; Sarnelli G; De Ponti F; Stanghellini V; Tonini M; Cappello S; Pagnotta E; Nobile-Orazio E; Corinaldesi R
Gastroenterology; 2003 Jul; 125(1):70-9. PubMed ID: 12851872
[TBL] [Abstract][Full Text] [Related]
18. Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library.
Behrends U; Jandl T; Golbeck A; Lechner B; Müller-Weihrich S; Schmid I; Till H; Berthold F; Voltz R; Mautner JM
Int J Cancer; 2002 Aug; 100(6):669-77. PubMed ID: 12209604
[TBL] [Abstract][Full Text] [Related]
19. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells.
Grandinetti KB; Spengler BA; Biedler JL; Ross RA
Oncogene; 2006 Feb; 25(5):706-12. PubMed ID: 16278682
[TBL] [Abstract][Full Text] [Related]
20. TAP/NXF1, the primary mRNA export receptor, specifically interacts with a neuronal RNA-binding protein HuD.
Saito K; Fujiwara T; Katahira J; Inoue K; Sakamoto H
Biochem Biophys Res Commun; 2004 Aug; 321(2):291-7. PubMed ID: 15358174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]